Business / Finance

RSS

The Ensign Group to purchase CHRISTUS St. Joseph Villa located in Utah

The Ensign Group, the parent company of the Ensign group of skilled nursing, rehabilitative care services, hospice care and assisted living companies, announced today that it has agreed to purchase CHRISTUS St. Joseph Villa, a continuing care retirement community located in Salt Lake City, Utah, and the CHRISTUS Marian Center, a behavioral health center operated within St. Joseph Villa.

21 Jan 2011

Northeast Ohio healthcare sector companies attracted $132 million in investments in 2010

In 2010, 62 Northeast Ohio companies collectively raised $221 million from venture capitalists and angel investors, an increase of 121 percent over the amount raised by companies in 2009. The growth rate of dollars invested in regional companies is higher than recently released data from Thomson Reuters showing a 19 percent increase in dollars invested nationally.

21 Jan 2011

Fresenius Medical Care to sell $500 million and €300 million senior notes

Fresenius Medical Care AG & Co. KGaA, the world's largest provider of dialysis products and services, today announced its intention to sell US$500 million of senior unsecured notes due 2021 issued by Fresenius Medical Care US Finance, Inc. and €300 million of senior unsecured notes due 2021 issued by FMC Finance VII S.A..

21 Jan 2011

St. Jude Medical reaches settlement agreement with DOJ over post-market study matter in Boston

St. Jude Medical, Inc., a global medical device company, today issued the following statement regarding a settlement agreement reached with the U.S. Department of Justice (DOJ) regarding a previously disclosed 2005 investigation in Boston related to an industry-wide review of post-market studies and registries:

21 Jan 2011

Teva invests $3.95M in Rexahn for development of anti-cancer compound RX-3117

Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and central nervous system (CNS) therapeutics, announced that Teva Pharmaceutical Industries Limited (Teva) purchased 2,334,515 shares of Rexahn's common stock in a private offering for $3.95 million, or $1.692 per share.

21 Jan 2011

IMDx enters multi-year agreement with Abbott Molecular for m2000 instrument system

IMDx today announced that they have signed a multi-year agreement with Abbott whereby IMDx will design, develop, regulatory clear, and manufacture assays for the Abbott Molecular FDA cleared, m2000 instrument system to be distributed worldwide. Financial terms have not been disclosed.

21 Jan 2011

NeoStem completes merger with Progenitor Cell Therapy

NeoStem, Inc. and Progenitor Cell Therapy LLC announced today the closing of their previously announced merger transaction.

21 Jan 2011

PSS World Medical announces acquisition of Dispensing Solutions

PSS World Medical, announced today that it has acquired Dispensing Solutions. DSI, a privately held company based in California, markets turn-key dispensing programs in the point of care, government, and contract packaging markets.

21 Jan 2011

Genzyme to expand Geel facility to support growth of Myozyme and Lumizyme for Pompe disease

Genzyme Corp. today announced that it will build an additional manufacturing plant in Geel, Belgium, to support the long-term growth of Myozyme® and Lumizyme® for Pompe disease.

20 Jan 2011

Cognition Therapeutics closes $2.5 million Series A1 financing

Cognition Therapeutics Inc., a drug discovery company developing novel, small molecule disease-modifying treatments for Alzheimer's, has closed on a $2.5 million Series A1 financing it will use to bring one or more of its compounds to Investigational New Drug (IND) candidate status. The round was led by Golden Seeds, one of the nation's largest angel investing groups, and was syndicated with Tech Coast Angels.

20 Jan 2011

Perrigo to acquire Paddock Labs for $540M in cash

Perrigo Company today announced that it has signed a definitive agreement to acquire substantially all of the assets of Paddock Laboratories, Inc., a privately-held, Minneapolis-based manufacturer and marketer of generic pharmaceutical products for approximately $540 million in cash. Perrigo expects to receive a significant tax benefit as a result of the acquisition of Paddock's assets. The net present value of this tax benefit is estimated to be $95 million.

20 Jan 2011

Meridian Bioscience first quarter net sales decrease 12% to $37.3 million

Net sales for the first quarter of fiscal 2011 were $37,263,000 as compared to $42,457,000 for the same period of the prior fiscal year, a decrease of 12%. Net earnings for the first quarter of fiscal 2011 were $6,025,000, or $0.15 per diluted share, both decreases of 32% from the first quarter of fiscal 2010. Diluted common shares outstanding for the first quarter of fiscal 2011 and 2010 were 41,294,000 and 41,185,000, respectively.

20 Jan 2011

FDA approves Spectranetics PMA for manufacturing site change for CVX-300 laser system

Spectranetics Corporation today announced that the Food and Drug Administration (FDA) has approved the Company's premarket approval application (PMA) supplement requesting a manufacturing site change for the CVX-300® laser system.

20 Jan 2011

UnitedHealth Group reports net earnings of $4.10 per share for 2010

UnitedHealth Group today reported fourth quarter and full year 2010 financial results, including strong revenue growth from both its Health Benefits and Health Services business platforms. Full year and fourth quarter 2010 net earnings were $4.10 per share and $0.94 per share, respectively.

20 Jan 2011

Ingenix announces formation of new Life Sciences division

Ingenix, a leading provider of health care information, technology and consulting services, today announced the formation of Ingenix Life Sciences, a newly-organized division that focuses Ingenix's capabilities in assisting life sciences clients to identify, analyze and measure the value of their products.

20 Jan 2011

inVentiv Health signs definitive agreement to purchase i3 clinical development businesses from Ingenix

inVentiv Health, a leading provider of outsourced clinical development, launch and commercial services to the global health care industry, today announced it has signed a definitive agreement to purchase the i3 clinical development businesses from Ingenix.

20 Jan 2011

Cognizant to deliver commercial operations solutions to Lilly

Cognizant, a leading provider of consulting, technology, and business process outsourcing (BPO) services, announced that it has been selected by Eli Lilly and Company, one the world's leading innovation-driven pharmaceutical companies, to deliver an end-to-end set of services to help Lilly's U.S. sales and marketing operations be more effective, efficient, and innovative.

20 Jan 2011

Medidata extends Grants Manager web-based budgeting application with new Contracting module

Medidata Solutions, a leading global provider of SaaS-based clinical development solutions, today extended the Grants Manager® web-based budgeting application with a new Contracting module, enabling sites and sponsors to negotiate clinical trial site budgets directly online, eliminating the burden of managing hundreds of email messages and reducing budgeting cycle times.

20 Jan 2011

Waters signs land-purchase agreement with Royal Bank of Scotland for new MS Headquarters in UK

Waters Corporation today announced it signed a land-purchase agreement with The Royal Bank of Scotland for a new Mass Spectrometry Headquarters in Wilmslow, Cheshire, near Manchester, U.K.

20 Jan 2011

Precedent Health announces formal launch

Precedent Health, Inc., a healthcare company focused on aligning physicians, hospitals and payers by building innovative provider networks, today announced the formal launch of the company. Funding was provided by Heritage Group, LLC, TEXO Ventures, LLC and members of the founding executive team. The company will have its headquarters in Nashville, TN along with a satellite office in Austin, TX.

20 Jan 2011

Business / Finance

The Ensign Group to purchase CHRISTUS St. Joseph Villa located in Utah

Northeast Ohio healthcare sector companies attracted $132 million in investments in 2010

Fresenius Medical Care to sell $500 million and €300 million senior notes

St. Jude Medical reaches settlement agreement with DOJ over post-market study matter in Boston

Teva invests $3.95M in Rexahn for development of anti-cancer compound RX-3117

IMDx enters multi-year agreement with Abbott Molecular for m2000 instrument system

NeoStem completes merger with Progenitor Cell Therapy

PSS World Medical announces acquisition of Dispensing Solutions

Genzyme to expand Geel facility to support growth of Myozyme and Lumizyme for Pompe disease

Cognition Therapeutics closes $2.5 million Series A1 financing

Perrigo to acquire Paddock Labs for $540M in cash

Meridian Bioscience first quarter net sales decrease 12% to $37.3 million

FDA approves Spectranetics PMA for manufacturing site change for CVX-300 laser system

UnitedHealth Group reports net earnings of $4.10 per share for 2010

Ingenix announces formation of new Life Sciences division

inVentiv Health signs definitive agreement to purchase i3 clinical development businesses from Ingenix

Cognizant to deliver commercial operations solutions to Lilly

Medidata extends Grants Manager web-based budgeting application with new Contracting module

Waters signs land-purchase agreement with Royal Bank of Scotland for new MS Headquarters in UK

Precedent Health announces formal launch

Precision in every drop: Inside Hamilton’s syringe technology

Exploring the Future of Neuroscience Drug Discovery

Genomic conservation in Thailand's mangroves

Latest News